ロード中...
Sacubitril/Valsartanstive Heart Failure: Cardiogenic Shock
Sacubitril/valsartan is a combination drug described as a new class of dual-acting angiotensin receptor-neprilysin inhibitor (ARNi) for heart failure. We present a case of a patient with NYHA class IV systolic heart failure who was refractory to all other classes of heart failure medications and was...
保存先:
| 出版年: | Case Rep Cardiol |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Hindawi
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5976952/ https://ncbi.nlm.nih.gov/pubmed/29862089 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/8231576 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|